The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.60
Bid: 160.40
Ask: 161.00
Change: -0.20 (-0.12%)
Spread: 0.60 (0.374%)
Open: 161.20
High: 161.40
Low: 160.60
Prev. Close: 160.80
TEM Live PriceLast checked at -
Templeton Emerging Markets is an Investment Trust

To provide long-term capital appreciation for private and institutional investors seeking exposure to global emerging markets, supported by both strong customer service and corporate governance.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues update on Templeton Emerging Markets

27 Feb 2023 08:48

RNS Number : 1272R
Templeton Emerging Markets IT PLC
27 February 2023
 

London, UK, 27 February 2023

 

Edison issues update on Templeton Emerging Markets IT (TEM)

Templeton Emerging Markets Investment Trust (TEMIT) has two very experienced managers: Chetan Sehgal (lead manager - based in Singapore) and Andrew Ness (based in Edinburgh). They are encouraged by the trust's improved absolute and relative performance in recent months as investors are focusing more on company fundamentals rather than macroeconomic developments. The managers seek quality companies with high returns and sustainable business models that are trading at a discount to their intrinsic values and TEMIT's resulting portfolio is broadly diversified by geography, sector and market cap.

 

TEMIT's 12.8% discount compares with the 9.3-16.4% range of discounts over the last 12 months. Over the last one, three, five and 10 years the trust's average discounts are 12.8%, 11.1%, 11.2% and 11.3% respectively. There is scope for the trust to be afforded a higher valuation if its relative performance continues to improve or investor sentiment towards emerging market equities becomes more favourable. 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPAXADDDEEA
Date   Source Headline
9th May 20248:36 amRNSNet Asset Value(s)
8th May 20248:35 amRNSNet Asset Value(s)
7th May 202410:31 amRNSNet Asset Value(s)
7th May 202410:03 amRNSCompliance with MAR, Article 19, Paragraph 11
3rd May 20248:45 amRNSNet Asset Value(s)
2nd May 20249:28 amRNSNet Asset Value(s)
1st May 202410:18 amRNSNet Asset Value(s)
1st May 20249:37 amRNSTotal Voting Rights
30th Apr 20249:05 amRNSNet Asset Value(s)
29th Apr 20244:57 pmRNSTransaction in Own Shares
29th Apr 202410:11 amRNSNet Asset Value(s)
26th Apr 20244:59 pmRNSTransaction in Own Shares
26th Apr 20248:38 amRNSNet Asset Value(s)
25th Apr 20248:52 amRNSNet Asset Value(s)
24th Apr 20244:58 pmRNSTransaction in Own Shares
24th Apr 20248:40 amRNSNet Asset Value(s)
23rd Apr 20244:58 pmRNSTransaction in Own Shares
23rd Apr 20249:27 amRNSNet Asset Value(s)
22nd Apr 20245:02 pmRNSTransaction in Own Shares
22nd Apr 202410:08 amRNSPortfolio Update
22nd Apr 20248:46 amRNSNet Asset Value(s)
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:46 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:52 pmRNSTransaction in Own Shares
17th Apr 20249:03 amRNSNet Asset Value(s)
16th Apr 20245:05 pmRNSTransaction in Own Shares
16th Apr 20248:36 amRNSNet Asset Value(s)
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 20249:00 amRNSNet Asset Value(s)
12th Apr 20244:51 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:54 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:53 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20245:02 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:53 pmRNSTransaction in Own Shares
8th Apr 20248:49 amRNSNet Asset Value(s)
5th Apr 20248:46 amRNSNet Asset Value(s)
4th Apr 20248:43 amRNSNet Asset Value(s)
3rd Apr 20244:13 pmRNSHolding(s) in Company
3rd Apr 20249:15 amRNSNet Asset Value(s)
2nd Apr 20245:00 pmRNSTransaction in Own Shares
2nd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20249:16 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20249:11 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.